Celldex Therapeutics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons :

2023 ▼
- Current
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015

Select the Ratio:

Gross Profit Margin ▼

None ▼

Gross Profit Margin ▼

CLDX Gross Profit Margin	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Revenue Change	156.11 %	272.73 %	64.42 %	455.75 %	384.38 %
Seq. Revenue Change	172.31 %	466.04 %	-72.29 %	-40.05 %	296.31 %
Revenue In Millions	$4.13	$1.52	$0.27	$0.97	$1.61
Gross Profit Margin	-	-	-	-	-
Gross Profit Margin Total Ranking	# 573	# 701	# 781	# 832	# 420
Gross Profit In Millions	$4.13	$1.52	$0.27	$0.97	$1.61
Y / Y Gross Profit Change	-	-	-	-	-
Seq. Gross Profit Change	-	-	-	-	-

New: More CLDX's historic Gross Margin results >>

Commenting fourth Quarter 2023 Gross Profit Margin

Celldex Therapeutics Inc has managed to improve its Revenue sequentially to $4 millions by 172.31 % faster than Gross Profit increase of 172.31 % to $4 millions, this led to contraction in Gross Profit Margin to 100 %, a new company low.

Observing fourth quarter 2023 results within In Vitro & In Vivo Diagnostic Substances industry 2 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 573, from total ranking in previous quarter at 701.
Learn about Gross Margin

CLDX's Gross Profit Margin fourth quarter 2023 Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 3
Healthcare Sector	# 121
Overall	# 572

Gross Profit Margin Statistics
High	Average	Low
100 %	100 %	100 %
(Dec 31 2023)

CLDX Gross Income Trends • More of CLDX's Profitabilty Ratios • CLDX Stock Quotes and Charts

Other Gross Profit Margin Profitability Ratios
CLDX's Cumulative Gross Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
CLDX's Gross Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for CLDX's Competitors
Gross Profit Margin Profit Margin for Celldex Therapeutics Inc 's Suppliers
Gross Profit Margin Profit Margin for CLDX's Customers

You may also want to know
CLDX's Annual Growth Rates	CLDX's Profitability Ratios	CLDX's Asset Turnover Ratio	CLDX's Dividend Growth
CLDX's Roe	CLDX's Valuation Ratios	CLDX's Financial Strength Ratios	CLDX's Gross Profit Growth
CLDX's Roa	CLDX's Inventory Turnover Ratio	CLDX's Growth Rates	CLDX's Dividend Comparisons

Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within In Vitro & In Vivo Diagnostic Substances Industry	Gross Profit Margin	Dec 31 2023 MRQ Gross Profit	Dec 31 2023 MRQ Revenue
Cardio Diagnostics Holdings Inc	100.00 %	$ 5.310	$ 5.310
Celldex Therapeutics inc	100.00 %	$ 4.131	$ 4.131
Volitionrx Limited	100.00 %	$ 0.244	$ 0.244
Myriad Genetics Inc	68.67 %	$ 135.000	$ 196.600
Lantheus Holdings Inc	64.91 %	$ 229.869	$ 354.108
Idexx Laboratories Inc	58.39 %	$ 526.167	$ 901.163
Aspira Women s Health Inc	57.00 %	$ 1.214	$ 2.130
Biomerica Inc	20.74 %	$ 0.325	$ 1.567

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com